Abstract
Abstract
Background
Gynecological cancer(s), including breast cancer patients in aftercare and survivors, need supportive strategies to cope with symptoms that are adapted to their individual needs and circumstances. Aromatherapy has potential to be such strategy, but (qualitative) empirical research taking users’ own views into consideration about the potential and challenge of aromatherapy is lacking.
Purpose
The purpose of the study is to gain insights from individualized aromatherapy as a supportive care treatment, regarding their use and evaluation by women with gynecological cancers in aftercare.
Methods
We conducted a study with a mixed-methods design, focused on qualitative research. Five essential oil products were given to 18 participants to apply individually over a 4-week period. After the intervention, qualitative semi-structured interviews were conducted. Further, we documented and assessed symptomatic burdens of the women (MYMOP2) before and after intervention quantitatively.
Results
Aromatherapy was customized by the participants according to their needs. It showed potential for relief of symptomatic burdens — especially nausea, peripheral neuropathy, pain, and sleep. Additionally, opportunities emerged to indirectly affect symptomatic burdens. These developed out of new coping strategies (e.g., sleep routines) or by combining with existing strategies (e.g., meditation). Furthermore, aromatherapy was successfully used to promote well-being and encourage mindfulness.
Conclusion
Our findings demonstrated the potential of aromatherapy as a supportive treatment modality that can be used as a kind of toolbox. Challenges, such as individual odor aversions and intolerances, and limitations due to medication or illness should be considered in future aromatherapy research.
Funder
Primavera
Charité - Universitätsmedizin Berlin
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Schloss J, Alschuler L, McDonell E (2019) Women’s cancers and complementary and integrative medicine. A focus upon prevention, disease management and survivorship. In: Adams J, Steel A, Broom A, Frawley J (eds) Women’s Health and Complementary and Integrative Medicine. Routledge, London, pp 63–76
2. Islam J, Harris GD (2018) Cancer Survivor Health Needs for Women. Prim Care 45(4):659–676
3. Bjerkeset E, Röhrl K, Schou-Bredal I (2020) Symptom cluster of pain, fatigue, and psychological distress in breast cancer survivors: prevalence and characteristics. Breast Cancer Res Treat 180(1):63–71
4. Mehnert-Theuerkauf A, Esser P (2022) [Survivorship care plans for cancer patients: the importance of risk stratification, self-management and health literacy in the age of digital care]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65(4):412–419
5. Armbrust R, Richter R, Woopen H, Hilpert F, Harter P, Sehouli J (2021) Impact of health-related quality of life (HRQoL) on short-term mortality in patients with recurrent ovarian, fallopian or peritoneal carcinoma (the NOGGO-AGO QoL Prognosis-Score-Study): results of a meta-analysis in 2209 patients. ESMO Open 6(2):100081
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献